AGNIESZKA GOLABEK: Open Payments
NPI 1346628567 · SECAUCUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,003 in 25 payments from 7 companies in 2025. Trend: 2023 $1,376 · 2024 $982 · 2025 $1,003
Food & beverage: $1,003
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $334 |
| ABBVIE INC. | 11 | $255 |
| PFIZER INC. | 2 | $125 |
| Lilly USA, LLC | 1 | $117 |
| AstraZeneca Pharmaceuticals LP | 1 | $114 |
| Smith+Nephew, Inc. | 1 | $41 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
Products named: Wegovy, UBRELVY, NURTEC ODT, ZEPBOUND, TEZSPIRE, VRAYLAR, BOTOX, GRAFIX PL.
Industry payments across NJ — which companies pay providers there.
